Biosyent Ownership

The market capitalization of Biosyent is C$131.94 Million. Biosyent retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run. Some institutional investors establish a significant position in stocks such as Biosyent in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Biosyent, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividends Paid is likely to climb to about 2 M in 2024, whereas Dividend Yield is likely to drop 0.01 in 2024. Common Stock Shares Outstanding is likely to climb to about 13.5 M in 2024, whereas Net Income Applicable To Common Shares is likely to drop slightly above 4.8 M in 2024. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biosyent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.